Dr Carlos Manrique De Lara, MD, FACS | |
2518 W Trenton Rd, Edinburg, TX 78539-8070 | |
(956) 661-9000 | |
(956) 686-7833 |
Full Name | Dr Carlos Manrique De Lara |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 36 Years |
Location | 2518 W Trenton Rd, Edinburg, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699740324 | NPI | - | NPPES |
096608703 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | K3794 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Carlos Manrique De Lara Mdpa | 2466435540 | 4 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.
A review of the available evidence underscores the safety of the federal childhood immunization schedule, according to a report released today by the Institute of Medicine. University of Michigan population ecologist Pejman Rohani served on the 13-person committee that wrote the report.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that it has agreed to sell approximately $3 million of its common stock and warrants to institutional investors in a registered direct offering.
› Verified 1 days ago
Entity Name | Carlos Manrique De Lara Mdpa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770558447 PECOS PAC ID: 2466435540 Enrollment ID: O20040610000078 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.
A review of the available evidence underscores the safety of the federal childhood immunization schedule, according to a report released today by the Institute of Medicine. University of Michigan population ecologist Pejman Rohani served on the 13-person committee that wrote the report.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that it has agreed to sell approximately $3 million of its common stock and warrants to institutional investors in a registered direct offering.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Carlos Manrique De Lara, MD, FACS Po Box 2706, Mcallen, TX 78502-2706 Ph: (956) 661-9000 | Dr Carlos Manrique De Lara, MD, FACS 2518 W Trenton Rd, Edinburg, TX 78539-8070 Ph: (956) 661-9000 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.
A review of the available evidence underscores the safety of the federal childhood immunization schedule, according to a report released today by the Institute of Medicine. University of Michigan population ecologist Pejman Rohani served on the 13-person committee that wrote the report.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that it has agreed to sell approximately $3 million of its common stock and warrants to institutional investors in a registered direct offering.
› Verified 1 days ago
Dr. Imtiaz A Mehkri, M.D., P.A. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 510 S Closner Blvd, Edinburg, TX 78539 Phone: 956-386-1122 Fax: 956-386-1133 | |
Dr. Mae E Wesson, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2005 West University Drive, Edinburg, TX 78541 Phone: 956-318-1400 | |
Dr. George Peter Amegin, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2005 W University Dr, Edinburg, TX 78539 Phone: 956-318-1400 Fax: 956-318-0022 | |
Dr. Lester W. Peacock, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2227 Cornerstone Blvd, Edinburg, TX 78539 Phone: 956-686-9696 | |
Dr. Vincent R Vann Jr., MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michael Angelo Dr, Suite 305, Edinburg, TX 78539 Phone: 956-630-2424 Fax: 956-630-2484 | |
Jai Narain Goel, DOMS Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2005 W University Dr, Edinburg, TX 78539 Phone: 956-399-8463 Fax: 956-399-8264 |